These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6878993)

  • 21. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles of measles control.
    Cutts FT; Henderson RH; Clements CJ; Chen RT; Patriarca PA
    Bull World Health Organ; 1991; 69(1):1-7. PubMed ID: 2054914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up measles campaign in the Dominican Republic.
    EPI Newsl; 1998 Dec; 20(6):4. PubMed ID: 12348924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
    Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
    Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measles control in developing countries].
    Cutts FT; Dabis F
    Sante; 1994; 4(3):163-71. PubMed ID: 7921681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles immunization: early two-doses policy experience.
    al-Mazrou YY; al-Jeffri M; Ahmed OM; Aziz KM; Mishkas AH
    J Trop Pediatr; 1999 Apr; 45(2):98-104. PubMed ID: 10341504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of low measles vaccination coverage in children living in an endemic area.
    Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
    Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A perspective on controlling vaccine-preventable diseases among children in Liberia.
    Weeks RM
    Infect Control; 1984 Nov; 5(11):538-41. PubMed ID: 6568218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles elimination in the Americas: a comparison between countries with a one-dose and two-dose routine vaccination schedule.
    Sever AE; Rainey JJ; Zell ER; Hennessey K; Uzicanin A; Castillo-Solórzano C; Dietz V
    J Infect Dis; 2011 Sep; 204 Suppl 2():S748-55. PubMed ID: 21954277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current impact of measles in Latin America.
    Borgoño JM
    Rev Infect Dis; 1983; 5(3):417-21. PubMed ID: 6878992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles in Israel, the West Bank, and Gaza: continuing incidence and the case for a new eradication strategy.
    Tulchinsky TH; Abed Y; Ginsberg G; Shaheen S; Friedman JB; Schoenbaum ML; Slater PE
    Rev Infect Dis; 1990; 12(5):951-8. PubMed ID: 2237137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guidelines for vaccination against measles in children].
    Avila-Figueroa C; Navarrete-Navarro S; Santos JI
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):528-33. PubMed ID: 2206422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
    O'Connor PM; Liyanage JB; Mach O; Anand A; Ramamurty N; Balakrishnan MR; Singh S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S396-402. PubMed ID: 21666190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress of EPI programs reviewed in Central American and Andean regions.
    EPI Newsl; 1995 Oct; 17(5):3-5. PubMed ID: 12290577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress Toward Measles Elimination - Pakistan, 2000-2018.
    Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.